Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Toxicity

Nov 02, 2022 03:10PM

Nov 02, 2022 03:46PM

Nov 02, 2022 03:51PM

Nov 02, 2022 03:53PM

Nov 02, 2022 04:19PM

Nov 02, 2022 04:59PM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Toxicity

in response to

Re: Toxicity

RVXoldtimer

posted on Nov 02, 2022 09:26PM

Apparently DM spoke about these stoppages in a small group discussion after the AGM. Maybe someone who was present could elaborate on his comments. Apparently the stoppage had nothing to do with ZEN-3694 but that is only what I've heard from an attendee.

tada

3 Recommendations

Re: Toxicity

jonzobot

Nov 03, 2022 03:28PM

Re: Toxicity

tada

Nov 03, 2022 04:08PM

Re: Toxicity

KOO-KOO2

Nov 03, 2022 04:50PM

Re: Toxicity